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1  | INTRODUC TION
African trypanosomes are single- cell extracellular hemoflagellate 
protozoan parasites and are transmitted between mammalian hosts 
via blood- feeding tsetse flies of the genus Glossina. The Trypanosoma 
brucei rhodesiense and T b gambiense subspecies cause human 
African trypanosomiasis in endemic regions within the tsetse fly belt 
across sub- Saharan Africa. Animal African trypanosomiasis is caused 
by Trypanosoma congolense, Trypanosoma vivax and T brucei and in-
flicts substantial economic strains on the African livestock industry.
The parasitic life cycle within the mammalian host is initiated 
by the intradermal injection of metacyclic trypomastigotes by the 
tsetse fly vector. The extracellular parasites then reach the draining 
lymph nodes, presumably via invasion of the afferent lymphatics and 
then disseminate systemically.1,2 During this process, the parasites 
also undergo morphological change into long slender bloodstream 
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Summary
African trypanosomes (Trypanosoma brucei spp.) are extracellular, hemoflagellate, 
protozoan parasites. Mammalian infection begins when the tsetse fly vector injects 
trypanosomes into the skin during blood feeding. The trypanosomes then reach the 
draining lymph nodes before disseminating systemically. Intravital imaging of the skin 
post- tsetse fly bite revealed that trypanosomes were observed both extravascularly 
and intravascularly in the lymphatic vessels. Whether host- derived cues play a role in 
the attraction of the trypanosomes towards the lymphatic vessels to aid their dis-
semination from the site of infection is not known. Since chemokines can mediate the 
attraction of leucocytes towards the lymphatics, in vitro chemotaxis assays were 
used to determine whether chemokines might also act as chemoattractants for tryp-
anosomes. Although microarray data suggested that the chemokines CCL8, CCL19, 
CCL21, CCL27 and CXCL12 were highly expressed in mouse skin, they did not stimu-
late the chemotaxis of T brucei. Certain chemokines also possess potent antimicrobial 
properties. However, none of the chemokines tested exerted any parasiticidal ef-
fects on T brucei. Thus, our data suggest that host- derived chemokines do not act as 
chemoattractants for T brucei. Identification of the mechanisms used by trypano-
somes to establish host infection will aid the development of novel approaches to 
block disease transmission.
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forms that are adapted for survival within the mammalian host. Early 
studies showed that in both cattle and goats infected with T vivax 
by tsetse fly bite, the parasites were detectable in the draining pre- 
scapular lymph nodes earlier than in peripheral blood during the ini-
tial period of infection.3,4 This progression has also been replicated 
in mice.2 Following their intradermal injection by tsetse fly bite, 
T brucei parasites were similarly first detected within the draining 
lymph nodes by 18 hours, and subsequently detected in the blood 
by 42 hours.2 These data raise the hypothesis that intradermally in-
jected trypanosomes initially infect the local lymphatics within the 
skin before subsequently infecting the bloodstream and spreading 
systemically. The currently licensed drugs that are available to treat 
trypanosomiasis have dangerous side- effects, and drug- resistance 
is an increasing problem. A fuller understanding of the mechanisms 
used by African trypanosomes to enable their systemic dissemina-
tion after infection would aid the development of novel approaches 
to block disease pathogenesis and transmission.
In the current study, intravital imaging revealed the novel finding 
that after injection into the skin African trypanosomes could be ob-
served both extravascularly and intravascularly within the lymphatic 
vessels. We therefore tested the hypothesis that host- derived cues 
such as chemokines may play a role in the attraction of the trypano-
somes towards the lymphatic vessels to enable their dissemination 
from the site of infection. Chemokines comprise a superfamily of 
8- 12 kDa globular proteins that play important roles in the attrac-
tion of lymphocytes and leucocytes towards the lymphatics and 
lymphoid tissues and coordinate their positioning within them.5,6 
Chemokines mediate their activities through interactions with spe-
cific G protein- coupled chemokine receptors, which trigger intracel-
lular pathways involved in cell motility and activation.7 For example, 
expression of the chemokines CCL19 and CCL21 by local lymphatic 
endothelial cells mediates the homing of chemokine receptor CCR7 
expressing dendritic cells.8 In this study, publicly available microar-
ray data sets were analysed to identify genes encoding chemokines 
that were highly expressed in mouse skin. In vitro assays were then 
used to test the hypothesis that these host- derived chemokines may 
act as chemoattractants for T brucei.
In addition to their role in coordinating the chemotaxis and po-
sitioning of cells within tissues, many chemokines also possess po-
tent antimicrobial properties, especially against certain pathogenic 
bacteria and fungi.9-13 These antimicrobial chemokines mediate 
their antimicrobial activities predominantly through the disruption 
and lysis of the pathogen cell membrane.9 Truncated variants of 
some CXC chemokines have also been reported to be directly bac-
tericidal for Bacillus subtilis, Escherichia coli, Lactococcus lactis and 
Staphylococcus aureus, and fungicidal against Cryptococcus neofor-
mans.14 The chemokine CCL28 has also been shown to have direct 
antimicrobial activity against bacteria and fungi, as well as direct 
parasiticidal effects against the protozoan parasite Leishmania mex-
icana,15 a kinetoplastid protozoan related to T brucei. Therefore, 
in the current study in vitro assays were also used to determine 
whether certain chemokines mediated any direct parasiticidal ef-
fects against T brucei.
2  | MATERIAL S AND METHODS
2.1 | Trypanosomes
In vitro cultivated monomorphic T b brucei Lister 427 strain trypano-
somes, pleomorphic T b brucei STIB247 strain and T b brucei STIB247 
trypanosomes16 expressing mCherry were used where indicated in 
this study. Bloodstream- form Lister 427 parasites were axenically 
cultivated	 in	vitro	at	37°C	 in	the	presence	of	5%	CO2 as previously 
described17 using Iscoves modified Dulbecco’s medium supplemented 
with hypoxanthine (1.36 g/mL; Invitrogen), bathocuproinedisulphonic 
acid disodium salt (2.82 mg/mL; Sigma), thymidine (3.3 mg/mL, Sigma), 
sodium pyruvate (22 mg/mL, Sigma), L- cysteine (18.2 mg/mL, Sigma), 
β- mercaptoethanol (0.2 mmol/L, Invitrogen), kanamycin (10 mg/mL, 
Invitrogen),	penicillin/streptomycin	(100	U/mL,	Invitrogen),	10%	foetal	
bovine	serum	(Invitrogen)	and	10%	foetal	bovine	Serum-	Plus	(Sigma).	
Bloodstream- form STIB247 parasites were cultivated in a modified 
recipe of the above medium with the addition of glucose (100 mg/
mL, Sigma), adenosine (13.4 mg/mL, Sigma), guanosine (14.2 mg/mL, 
Sigma),	methylcellulose	 (110	mg/mL,	Sigma),	 and	20%	 foetal	bovine	
serum	and	20%	foetal	bovine	Serum-	Plus.
2.2 | In vivo imaging
All in vivo procedures were carried out at the University of Glasgow 
in accordance with United Kingdom Home Office regulations under 
the authority of the appropriate project and personal licenses. 
Prox- 1 mOrange mice18 were anesthetised using a freshly prepared 
1:1	mixture	of	Hypnorm	(25	mg/kg)	and	Hypnovel	(12.5	mg/kg)	in-
jected intraperitoneally. The hair on the mouse ear to be imaged was 
removed	by	applying	a	hair	removal	cream	(Nair)	to	the	mouse	ear	
for 2 minutes, and then excess was removed with a damp tissue. The 
mouse was then placed on a custom built imaging platform, and core 
body temperature was continuously monitored by a rectal probe 
and maintained by a thermostatically controlled heat mat at 37°C. 
The mouse ear was immobilised on the imaging platform using glue 
(3M Vetbond) which was set on the addition of phosphate buffered 
saline. Prior to imaging, the mouse ear was injected intradermally 
with 10 μL containing 1 × 106 bloodstream form T b brucei STIB247 
trypanosomes expressing mCherry.16 Multiphoton imaging was per-
formed using a Zeiss LSM7 MP system equipped with both a 10X/0.3 
NA	air	and	20X/1.0NA	water-	immersion	objective	lens	(Zeiss).	Two,	
fully tunable excitation wavelengths were produced by a Titanium/
sapphire (Ti/S) solid- state 2- photon excitation source (Chameleon 
Ultra II; Coherent Laser Group), coupled to an optical paramet-
ric oscillator (OPO, Coherent Laser Group). A Ti/S laser output of 
820 nm and OPO signal of 1030 and 1090 nm provided excitation 
of mCherry and mOrange. Images were acquired for approximately 
15-	20	minutes	 and	 3D	 tracking	 was	 performed	 using	 Volocity	
6.1.1	 (Perkin	 Elmer)	 and	 Imaris	 7.6.5	 software	 (Bitplane,	 Oxford	
Instruments). Parasite turning angles were calculated using MATLAB 
software (Mathworks, version R2016b). Images were collected from 
5	individual	mice	and	2-	3	fields	of	view/mouse.
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2.3 | Microarray data
The	NCBI	Gene	Expression	Omnibus	database	 (http://www.ncbi.
nlm.nih.gov) was searched for mouse skin expression data sets 
on the Affymetrix mouse genome 430 2.0 microarray platform. 
Three independent studies which included normal, uninfected, 
wild-	type	mouse	skin	were	publicly	available	(GSE17511,	GSE7694,	
GSE27628), and the raw data sets (.cel files) were downloaded. The 
quality of the raw data was analysed and normalised using Robust 
Multichip Analysis (RMA EXPRESS; http://rmaexpress.bmbolstad.
com/) and annotated using the library file available from Affymetrix 
(release 36, 13/4/16; http://www.affymetrix.com/).
2.4 | Chemotaxis assays
All recombinant mouse chemokines used in this study were purchased 
from Peprotech (London, UK). For chemotaxis assays, triplicate cul-
tures were established as follows: Chemokines were suspended 
in the relevant trypanosome culture medium and 600 μL added to 
the corresponding wells of 24- well plates (Thermo Scientific). Heat- 
inactivated	 chemokines	 (treatment	 at	 95°C	 for	 5	minutes)	 or	 me-
dium alone were used as negative controls. A 3 μm trans- well insert 
(Millipore Europe) was added to each well, and 1 × 106 trypanosomes 
in 100 μL media subsequently added to the upper chamber. The 
plates	were	incubated	for	2	hours	at	37°C	in	the	presence	of	5%	CO2, 
and the number of trypanosomes that had passed through the trans- 
well insert pore into the lower chamber was counted in triplicate 
using	 an	 improved	 Neubauer	 haemocytometer.	 Experiments	 were	
repeated three times. Mouse splenocytes were also assessed as a 
positive chemotaxis control. Splenocytes were isolated in fresh RPMI 
1640	 media	 (5	mL	 of	 penicillin/streptomycin,	 5	mL	 of	 L-	glutamine	
and	0.1%	fatty	acid-	free	BSA	(Sigma-	Aldrich)	in	0.5	L	of	RPMI	solu-
tion) by gently mashing them through a 70 μmol/L cell EASYstrainer 
cell	sieve	(Greiner).	Next,	1	×	105 splenocytes suspended in 100 μL 
of media were added to the upper wells of 3 μmol/L pore inserts 
(Millipore Europe), and 600 μL of chemokine- containing medium 
or RPMI 1640 medium was added to the bottom wells. The plates 
were	incubated	for	2	hours	at	37°C	in	the	presence	of	5%	CO2, and 
the cells that had passed through the transwell insert pore into the 
lower chamber collected. The cells were stained for FACS analysis 
using	the	following	antibodies:	anti-	B220/CD45R-	BV605	(RA3-	6B2;	
Biolegend);	anti-	CD3-	PB	(145-	2c11;	Biolegend);	and	anti-	CD11c-	PE	
(N418;	BD	Pharmingen).	Cells	were	acquired	on	a	BD	Fortessa	LSR	
flow cytometer running FACSDiva and analysed using FlowJo 10.1 
analysis software (FlowJo LLC).
To determine effects of chemokine treatment on trypanosome 
motility, T brucei Lister 427 parasites were treated with the chemo-
kines CCL21, CCL27 and CCL28 or media alone as above at 37°C 
in	 the	presence	of	 5%	CO2 for 2 hours. The trypanosomes where 
then transferred to chambered slides (Lab- Tek Chambered Coverslip 
no.	 1.5;	 Thermo	Scientific),	 placed	on	 a	 heated	 stage,	 and	 viewed	
using a Zeiss Axiovert 100 inverted microscope. Videos of trypano-
some	motility	 in	 each	 condition	 (30	 secs	 long,	 50	 frames/s)	 were	
recorded using a Hamamatsu digital camera (Low- light, Hamamatsu 
Photonics) and Micro- manager 18.1.14 imaging software (ImageJ 
plug-	in,	 NIH).	 Trypanosome	 motility	 in	 the	 videos	 was	 then	 sub-
sequently analysed using Imaris 8.1.2 software (Bitplane, Oxford 
Instruments). For each treatment condition, data for 90 individual 
trypanosomes were collected (30 trypanosomes/condition for each 
of 3 independent experiments).
2.5 | Cytotoxicity assays
For cytotoxicity assays, triplicate cultures of 8 × 105 trypanosomes 
in 100 μL medium were added to each well of a 96- well plate. 
Chemokine- containing medium (200 μL/well) was then added to 
each	well	at	a	final	concentration	of	10,	100	or	500	ng/mL.	Heat-	
inactivated	chemokines	 (treatment	at	95°C	for	5	minutes.)	or	me-
dium alone were used as controls. The plates were incubated for 
2	hours	at	37°C	in	the	presence	of	5%	CO2, and the number of via-
ble	trypanosomes	counted	in	triplicate	using	an	improved	Neubauer	
haemocytometer. Experiments were repeated three times.
2.6 | Membrane permeability assays
Trypanosoma brucei Lister 427 trypanosomes were treated with 
500	ng/mL	of	chemokines	or	10	μmol/L of the anti- trypanosome drug 
Berenil (diminazine aceturate, as a positive control) in 100 μL of media 
for 2 hours as described above. The parasites were then diluted 1:2 in 
PBS	containing	4%	propidium	iodide	(PI)	and	incubated	in	the	dark	for	
30 minutes on ice. Uptake of PI into cells was then determined using a 
BD FACS Calibur cytometer and FlowJo 10.1 analysis software.
Trypan blue- exclusion was used to determine the number of 
live or dead trypanosomes present following chemokine treatment. 
Approximately 8 × 105 trypanosomes in 100 μL medium were added 
to each well of a 96- well plate. Chemokine- containing medium 
(200 μL/well) was then added to each well at a final concentration 
of	 500	ng/mL.	 The	 anti-	trypanosome	 drug	 Berenil	 was	 used	 as	 a	
control at concentrations of 1, 2 and 10 μmol/L. The plates were in-
cubated	for	2	hours	at	37°C	in	the	presence	of	5%	CO2. Afterwards, 
the parasites were suspended in trypan blue dye and the number of 
live and dead trypanosomes counted using a haemocytometer.
2.7 | Transmission electron microscopy (TEM)
To assess the impact of chemokine treatment on the morpho-
logical integrity of the parasites, monomorphic T brucei Lister 427 
trypanosomes were treated with chemokine- containing media 
(500	ng/mL),	 the	 trypanocidal	 drug	Berenil	 (diminazine	 aceturate,	
10 μmol/L) as a positive control or medium alone as a negative con-
trol. After 2 hours of exposure, the parasites were then processed 
for TEM imaging. Samples were washed in PBS to remove excess 
media	 and	 resuspended	 in	 3%	 gluteraldehyde.	 Trypanosome	 pel-
lets were then treated with 0.1 M sodium cacodylate buffer (pH 7.2) 
for 2 hours and washed three times for 10 minutes in fresh 0.1 M 
sodium	cacodylate	buffer.	The	samples	were	then	post-	fixed	in	1%	
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osmium	 tetroxide	 in	0.1	M	sodium	cacodylate	 for	45	minutes	and	
washed further three times for 10 minutes in fresh 0.1 M sodium 
cacodylate buffer. The samples were then dehydrated in increasing 
concentrations of ethanol and subsequently treated with propylene 
oxide. The samples were then embedded in TAAB 812 resin (TAAB 
Laboratories Equipment Ltd), and sections (1 μm thick) stained with 
toluidine blue and viewed under a light microscope. Ultra- thin sec-
tions (60 nm thick) were then cut from the areas of interest and 
stained in uranyl acetate and lead citrate for being analysed by TEM.
2.8 | Statistical analysis
All data are derived from three independent experiments. Statistical 
analyses were performed using GraphPad Prism 6.01 (Graphpad 
Software, Inc.). Multiple comparisons between multiple groups from 
independent	 experiments	were	 analysed	using	multi-	way	ANOVA	
with Tukey’s multiple comparisons test. On each graph, the indi-
vidual replicates are shown, whereas the horizontal bar represents 
the mean ± SD.
3  | RESULTS
3.1 | Trypanosomes can be found in skin lymphatic 
vessels after intradermal injection
A previous study in mice2 has shown that following the intradermal 
injection by tsetse fly bite, T brucei parasites were first detected 
within the draining lymph nodes by 18 hours and subsequently 
detected in the blood by 42 hours. This raised the hypothesis that 
trypanosomes initially infect the lymphatic vessels in the skin after 
intradermal injection to disseminate from the site of infection. We 
used intravital imaging to visualise trypanosomes following injection 
into the skin. T brucei could be observed both extravascularly and in-
travascularly in the lymphatic vessels (Figure 1A and Movie S1). The 
trypanosomes detected within the lymphatics had a significantly 
higher velocity compared with extra- lymphatic parasites (Figure 1B; 
P < 0.001). The majority of extravascular parasites appeared to be 
moving non- randomly, towards or away from the lymphatic vessels 
as assessed by turning angle (turning angles 0° or 180°, respectively; 
(Figure 1A, C & D), with individual parasites repeatedly moving to-
wards, then away, then back again. If static parasites were excluded 
from	 this	 analysis	 (those	 moving	 <5	μm between frames), this bi-
modal distribution was particularly clear (Figure 1D).
3.2 | Chemokine gene expression in mouse skin
Since trypanosomes were detected within lymphatic vessels after 
intradermal injection, we hypothesized that the parasites may be 
responsive to host- derived cues such as chemokines and use them 
to aid their dissemination from the site of infection. We therefore 
compared the expression of chemokine- encoding genes in mouse 
skin using publicly available collections of microarray data. Data 
from three independent studies were analysed (GEO accession 
codes:	GSE17511;	GSE7694;	GSE27628)	comprising	a	total	of	11	in-
dividual microarrays (data sets) performed on the Affymetrix mouse 
genome 430 2.0 platform. This analysis showed that genes encod-
ing the chemokines CCL6, CCL8, CCL21, CCL27, CXCL12, CXCL14 
and CXCL16 were expressed highly in the mouse back, ear and tail 
skin data sets (Figure 2A,B). Of these, the chemokines CCL8, CCL21, 
CCL27 and CXCL12 were selected for use in subsequent experi-
ments, due to their high expression levels in the mouse skin regions. 
We also included CCL19 since this chemokine, together with CCL21, 
also contributes to the homing of lymphocytes and leucocytes 
across the vascular endothelium.8,19
3.3 | Effects of in vitro chemokine exposure on the 
chemotaxis and motility of T brucei
To determine whether certain chemokines may act as chemoat-
tractants for T brucei, standard chemotaxis assays were performed. 
Monomorphic T brucei Lister 427 trypanosomes were placed in the 
upper chamber of each well, which was separated from the lower 
chamber by a 3 μm pore membrane. Differing concentrations of each 
chemokine were then added to the medium in the lower chamber 
and the number of trypanosomes that had migrated into the lower 
chamber was determined 2 hours later. Heat- inactivated chemokines 
and medium alone were used as controls. The chemokines CCL8, 
CCL19, CCL21, CCL27 and CXCL12 did not stimulate significant 
chemoattraction of T brucei when compared to controls (Figure 3). 
This observation was not specific to the monomorphic T brucei Lister 
427 parasite strain since a parallel set of experiments showed that 
CCL21 also exerted no significant chemoattraction towards the ple-
omorphic T brucei STIB 247 strain (Figure 3F). As anticipated, these 
chemokines mediated significant chemoattraction of mouse spleno-
cytes (Figure S1).
We also assessed whether exposure to these chemokines might 
alter trypanosome motility characteristics. The chemokine CCL21 
was used in these studies due to its role in stimulating the homing 
of lymphocytes/leucocytes to lymphoid tissues and their migration 
across the vascular endothelium.19 Monomorphic T brucei Lister 
427 trypanosomes were incubated in medium containing CCL21 for 
2 hours, and the motility of 90 individual parasites was recorded by 
live cell imaging. Imaris software was then used to determine the ef-
fects of treatment on trypanosome speed, as well as their velocities 
in the X and Y axes. Consistent with data presented in Figure 3, our 
analysis clearly showed that CCL21 exposure did not significantly 
affect trypanosome speed or velocity when compared to control- 
treated trypanosomes (Figure 4).
3.4 | Effects of in vitro chemokine exposure on 
trypanosome viability
As well as mediating the migration and position of certain host cell 
populations within tissues, some chemokines can display antimicro-
bial activities towards a range of microbial pathogens.12,15,20,21 We 
therefore determined whether chemokines might also exhibit direct 
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parasiticidal effects. Monomorphic T brucei Lister 427 trypanosomes 
were incubated with differing concentrations of each chemokine 
and the number of viable trypanosomes determined 2 hours later. 
In these experiments, the chemokine CCL28 was also included 
since it had been shown in an independent study to exert potent 
antimicrobial effects towards bacteria and fungi21,22 and the related 
protozoan parasite L mexicana.15 Heat- inactivated chemokines and 
medium alone were used as controls. Our data show that the vi-
ability of T brucei was not significantly affected after in vitro expo-
sure to CCL8, CCL19, CCL21, CCL27, CCL28 and CXCL12 (Figure 5).	
As above, this was not specific to the monomorphic T brucei Lister 
427 strain of trypanosomes as CCL21 and CCL28 also exerted 
no significant effect on the pleomorphic T brucei STIB 247 strain 
(Figure 5G,H).
3.5 | Effects of in vitro chemokine exposure on 
membrane permeability and integrity
Some chemokines have been shown to mediate their antimicro-
bial effects by causing direct damage to the plasma membranes of 
the target microorganism, including the protozoan parasite L mexi-
cana.15 We therefore determined whether the membrane integrity 
F IGURE  1  Intravital imaging shows 
T brucei could be observed both 
extravascularly and intravascularly in the 
lymphatic vessels after injection into the 
skin. A, Still images from Movie S1 show 
T brucei parasites (red) present adjacent 
to and within lymphatic vessels (white) 
in the skin of Prox1 mOrange reporter 
mice. B, Analysis of parasite velocities 
in Movie S1 revealed that intravascular 
parasites displayed greater speed of 
movement compared with extravascular 
parasites. ***P < 0.001. Furthermore, 
parasites adjacent to lymphatic vessels 
displayed directional movement towards 
or away from lymphatic vessels (identified 
by arrows in (A) and parasite tracking 
data (C)). D, Analysis of parasite tracks 
in panel C and Movie S1 confirmed that 
the parasites had a bimodal distribution 
of turning angles, suggesting directional 
movement in the skin. Exclusion of static 
parasites from the analysis (red line) made 
this conclusion more evident. Scale bars, 
50	μm. White broken lines in A and C 
outline the lymphatic vessels. Images and 
movie	are	representative	of	5	mice	and	
2- 3 fields of view/mouse
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of chemokine- treated T brucei parasites was affected by assess-
ing their uptake of the vital dyes propidium iodide (PI) and trypan 
blue. Flow cytometry was used to determine the number of trypa-
nosomes which were sufficiently permeabilized after treatment to 
allow entry of PI (Figure 6A- C), whereas trypan blue- exclusion was 
used to compare the effects of treatment on the number of live or 
dead trypanosomes (Figure 6D). Trypanosomes exposed to medium 
alone were used as controls. When trypanosomes were treated with 
the trypanocidal drug Berenil (diminazine aceturate, as a positive 
control) membrane integrity, and trypanosome viability was dra-
matically affected as anticipated (Figure 6). However, exposure to 
the chemokines CCL8, CCL19, CCL21, CCL27, CCL28 and CXCL12 
had no significant effect on membrane integrity when compared to 
control- treated trypanosomes (Figure 6).
Finally, TEM was used to determine whether chemokine expo-
sure caused morphological damage to the plasma membranes of 
the trypanosomes. As anticipated, substantial trypanosome de-
struction was observed following in vitro treatment with the try-
panocidal drug Berenil (Figure 7). However, no observable effects 
on membrane integrity were observed following treatment with the 
chemokines CCL21, CCL27 or CCL28 when compared to control- 
treated trypanosomes (Figure 7).
4  | DISCUSSION
Understanding the nature of and cues that trigger trypanosome 
movement in and between different tissue compartments is poorly 
understood, despite being critical to the progression of the parasite’s 
life cycle in the mammalian and insect hosts. This aspect of trypa-
nosome behaviour is of particular interest given recent studies that 
have described tissue- specific populations (skin and adipose),2,23,24 
highlighting gaps in our knowledge of where and how trypanosomes 
disseminate in the mammalian host. Data in the current study show 
that following injection into the skin many of the trypanosomes 
could be observed migrating directly towards or away from the lym-
phatic vessels. Furthermore, some of the trypanosomes were also 
detected within the afferent lymphatic vessels in the dermis. These 
F IGURE  2 Retrospective comparison 
of chemokine gene expression in mouse 
skin. Heat maps show the expression of 
profile of multiple CCL (A) or CXCL (B) 
chemokine- encoding probe sets in the 
samples of back, ear and tail skin (GEO 
accession	codes:	GSE17511;	GSE7694;	
GSE27628). These data were performed 
on Affymetrix MOE430_2 mouse genome 
expression arrays (Affymetrix, Santa 
Clara, CA). Each column represents 
the mean probe set intensity (log2) for 
individual data sets (samples) from each 
source. Representative probe set are 
shown when multiple probe sets for a 
gene were present on the arrays
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data are consistent with those in an independent study which has 
shown that following the intradermal injection of T brucei parasites 
by tsetse fly bite, the parasites were first detected within the drain-
ing lymph nodes within hours of infection before their subsequent 
detection within the bloodstream.2 Leucocytes and lymphocytes are 
specifically attracted to lymphatic endothelial cells along chemokine 
gradients, and their interactions with specific adhesion molecules 
coordinate their adhesion to and migration across the endothe-
lium.25,26 Given that some trypanosomes were observed migrating 
within the lymphatics we hypothesised that the parasites may be re-
sponsive to host chemokines and use them to aid their dissemination 
from the site of infection. However, our in vitro studies show that 
the chemokines CCL8, CCL19, CCL21, CCL27 and CXCL12 do not 
stimulate the chemotaxis or influence the motility of T brucei. This 
effect was evaluated using bloodstream forms of both monomorphic 
T brucei 427 and pleomorphic T brucei 247 parasite. Thus, our data 
suggest that the parasites are unlikely to use these chemokines as 
cues to aid their dissemination from the injection site in the skin.
F I G U R E  3 Effect of in vitro chemokine exposure on trypanosome chemotaxis. 1 × 106 viable monomorphic T brucei Lister 427 
trypanosomes (A- E) or pleomorphic T brucei STIB 247 trypanosomes (F) were placed in the upper chamber of each well which was separated 
from the lower chamber by a 3 μm pore membrane. The respective concentration of (A) CCL8, (B) CCL19, (C,F) CCL21, (D) CCL27 and (E) 
CXCL12 were then added to the medium in the lower chamber and the number of trypanosomes which had migrated into the lower chamber 
determined	2	h	later.	Heat-	inactivated	chemokine	(i500,	i100)	or	medium	alone	were	used	as	negative	controls.	Each	point	represents	the	
mean from triplicate wells, and the horizontal bar represents the mean ± SD. All experiments were repeated three times on different days
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Data from elegant in vitro high- speed fluorescence microscopy 
studies have shown that the mode and dynamics of trypanosome 
locomotion can be influenced by the density of the surrounding 
matrix.27 In blood, the trypanosomes display efficient forward mo-
tion27 and this appears important to help avoid immune- mediated 
clearance.28 However, when the parasites become trapped, such as 
in a densely packed environment that resembles collagen networks 
or tissue spaces, the parasites reverse their flagellar beat and swim 
backwards.27 This apparent ability of the trypanosomes to adjust 
the beating direction of their flagellum in response to mechanical 
cues may help to explain the motility characteristics of the parasites 
that we observed following their injection into the skin. Within the 
dermis, the trypanosomes could be visualised migrating towards and 
away from the lymphatics, with individual parasites repeatedly mov-
ing towards, then away, then back again. Furthermore, the trypano-
somes within the lymphatics had significantly faster velocity when 
compared to those in the extra- lymphatic environment.
A recent study showed that there was a transient upregulation 
of	the	genes	encoding	CXCL1	and	CXCL5	in	the	dermis	of	mice	after	
bites from T brucei infected tsetse flies.29 We did not test the ef-
fects of these chemokines on trypanosome motility or viability in the 
current study. However, since these chemokines are typically pro-
duced by epithelial cells in response to damage to recruit cells such 
as neutrophils,30 we consider they would be unlikely to contribute 
to the specific chemoattraction of trypanosomes towards lymphatic 
vessels.
Infection in the mammalian host is initiated by the intradermal injec-
tion of metacyclic trypomastigotes by the tsetse fly vector. While the 
precise timing is uncertain, these parasites then undergo morphological 
change into the long slender bloodstream forms that are adapted for 
survival within the mammalian host. The chemotaxis studies utilized 
in vitro cultivated bloodstream trypanosome forms, thus it is plausible 
that the chemokines tested may differ in their activity against meta-
cyclic forms. However, an in silico protein- protein sequence compari-
son	(NCBI	BLAST	search)	found	no	matches	for	homologues	of	murine	
chemokine receptors in T brucei genome data (data not shown).
The endothelium of the collecting initial lymphatics typically has 
incomplete or absent intercellular junctions. The loosely connected, 
overlapping borders of these lymphatic endothelial cells are consid-
ered to facilitate the unidirectional entry of tissue fluid and proteins 
into the lymphatics along hydrostatic pressure and protein gradi-
ents.31,32 While it is plausible that African trypanosomes migrate 
towards the lymphatics by sensing lymph flow, this current is insuffi-
cient to push leucocytes such as classical dendritic cells towards the 
initial lymphatics.26
Batrachochytrium dendrobatidis is an important fungal pathogen 
of amphibians. The zoospores of this pathogen have been shown to 
exhibit chemotaxis towards nutritional cues including sugars, proteins 
and amino acids.33 Within the mammalian host, T brucei derives its 
metabolic energy from blood glucose using a unique form of glycoly-
sis.34 Since the concentration of glucose in the lymph has been shown 
to be higher than the bloodstream,35 it is possible that glucose may act 
as a molecular cue for T brucei following injection into the skin.
Increasing evidence shows that many chemokines also possess 
potent antimicrobial properties against certain pathogens.10 All of 
the chemokines tested for parasiticidal activity in this study have 
been shown to demonstrate this activity: CCL8 and CCL19 are 
bactericidal against the Gram- negative bacterium E coli11; CCL21 
is bactericidal against E coli and the Gram- positive bacterium S au-
reus11; CCL27 has fungicidal activity against Candida albicans22; and 
CXCL12 is bactericidal against S aureus and the E coli.11 The chemo-
kine CCL28 was of particular interest since it has been shown to 
exert broad- spectrum antimicrobial effects towards Gram- positive 
bacteria and Gram- negative bacteria,21,22 fungicidal activity towards 
C albicans22 and parasiticidal activity towards the protozoan parasite 
L mexicana.15 However, none of the chemokines tested in the current 
F I G U R E  4 Effect of in vitro CCL21 exposure on trypanosome 
motility. Monomorphic T brucei Lister 427 trypanosomes were 
incubated in medium containing CCL21 for 2 h and the motility 
of 90 individual parasites recorded by live cell imaging. Imaris 
software was then used to determine the effects of treatment 
on trypanosome speed, as well as their velocities in the X and Y 
axes. Each point represents data from the analysis of individual 
trypanosomes, and the horizontal bar represents the mean ± SD
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study exerted any observable parasiticidal effects towards T brucei. 
Many of these antimicrobial chemokines mediate their activities 
through the disruption and lysis of the pathogen cell membrane.10 
However, in our studies the membrane integrity of T brucei was not 
adversely affected after chemokine exposure. The human chemok-
ines CXCL2, CXCL6, CXCL9, CXCL10, CCL20 and CCL28 have been 
shown to exert their parasiticidal effects against L mexicana by ad-
versely affecting mitochondrial activity.15 However, a similar mode 
F I G U R E  5 Effect of in vitro chemokine exposure on trypanosome viability. Viable monomorphic T b brucei Lister 427 trypanosomes (A- F) 
or pleiomorphic T brucei STIB 247 trypanosomes (G,H) (8 × 105/1 mL well) were incubated in medium containing differing concentrations 
of (A) CCL8, (B) CCL19, (C,G) CCL21, (D) CCL27, (E) CXCL12 and (F,H) CCL28 were then added to the medium and the number of viable 
trypanosomes	determined	2	h	later.	Heat-	inactivated	chemokine	(i500,	i100,	i10)	or	medium	alone	were	used	as	control.	Each	point	
represents the mean from triplicate wells, and the horizontal bar represents the mean ± SD. All experiments were repeated three times on 
different days
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F IGURE  6 Effect of in vitro chemokine exposure on trypanosome membrane permeability and viability. A, Flow cytometric analysis of PI- 
uptake by trypanosomes after chemokine exposure. T brucei	Lister	427	trypanosomes	were	exposed	for	2	h	to	500	ng/mL	of	CCL21,	CCL27	
or CCL28, or 10 μmol/L of the anti- trypanosome drug Berenil (diminazene aceturate) before analysis. The percentage PI- positive cells in the 
gated regions of each scatter plot are shown. B, Histoplot shows the relative cell count vs PI uptake following exposure of T brucei Lister 427 
trypanosomes to medium alone (control, red), CCL21 (light blue), CCL27 (dark blue), CCL28 (green) or Berenil (shaded). C, Histogram shows 
the	%	PI-	positive	trypanosomes	following	in	vitro	exposure	to	chemokines	or	the	trypanocidal	drug	Berenil.	Each	bar	represents	the	mean	
from three independent experiments ± SD. D, Histogram shows the percentage live and dead trypanosomes after exposure to chemokines 
or the anti- trypanosome drug Berenil. All experiments were repeated three times on different days
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of action against bloodstream T brucei is unlikely since this life cycle 
stage lacks significant mitochondrial function.36 Although the above 
Leishmania study investigated the effects of chemokines on the pro-
mastigote forms of parasite which share similar dimensions, flagellar 
motility and extracellular niche to that of T brucei, it is plausible that 
antimicrobial chemokines may be more effective against intracellular 
pathogens. Within cells, the intracellular chemokine concentrations 
may be much higher, or the chemokine may disturb the intracellular 
niches in which the pathogens reside. For example, human CXCL4 
can kill erythrocyte- inhabiting Plasmodium falciparum parasites by 
selectively lysing the parasitic digestive vacuole.37
Together, our data show that following injection into the skin 
some of the trypanosomes could be observed migrating intravascu-
larly within the afferent lymphatic vessels in the dermis. However, the 
cues that the trypanosomes might exploit to enable them to infect 
the lymphatic vessels are not known. Identification of the mecha-
nisms used by African trypanosomes to establish host infection after 
intradermal injection into the skin would aid the development of 
novel prophylactic approaches to block their systemic dissemination 
in the mammalian host and reduce disease transmission.
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